Phase II study of chemoselection with docetaxel plus 5-fluorouracil and cisplatin induction chemotherapy and subsequent conversion surgery for locally advanced unresectable esophageal cancer

Authors :: Yasuhiro Tsubosa
Yasunori Akutsu
Yasushi Kojima
Tomoya Yokota
Yasuo Hamamoto
Hiroki Hara
Shuichi Hironaka
Yushi Nagai
Keisho Chin
Yoshinori Ito
Hisayuki Matsushita
Takayuki Kii
Kentaro Kawakami
Hirofumi Ogawa
Ken Kato
Yuko Kitagawa
Takashi Ura
Chika Asami
Keita Mori
Takashi Kojima
Source :: Journal of Clinical Oncology. 34:4021-4021
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: 4021Background: This multicenter phase II trial assessed the safety and efficacy of docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy (IC) and subsequent conversion surgery (...

Subjects :: Cisplatin
Cancer Research
medicine.medical_specialty
business.industry
Locally advanced
Induction chemotherapy
Phases of clinical research
Surgery
Unresectable Esophageal Cancer
Oncology
Docetaxel
Fluorouracil
medicine
business
medicine.drug

Full Text Access

Tools